Cargando…

The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial

OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Judith, Forde, Rita, Brackenridge, Anna, Hunt, Katharine F., Ismail, Khalida, Murrells, Trevor, Reid, Anna, Rogers, Helen, Rogers, Rebecca, Forbes, Angus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803154/
https://www.ncbi.nlm.nih.gov/pubmed/36584120
http://dx.doi.org/10.1371/journal.pone.0273992
_version_ 1784861817765363712
author Parsons, Judith
Forde, Rita
Brackenridge, Anna
Hunt, Katharine F.
Ismail, Khalida
Murrells, Trevor
Reid, Anna
Rogers, Helen
Rogers, Rebecca
Forbes, Angus
author_facet Parsons, Judith
Forde, Rita
Brackenridge, Anna
Hunt, Katharine F.
Ismail, Khalida
Murrells, Trevor
Reid, Anna
Rogers, Helen
Rogers, Rebecca
Forbes, Angus
author_sort Parsons, Judith
collection PubMed
description OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hospitals, UK. PARTICIPANTS: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m(2). INTERVENTION: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources. OUTCOME MEASURES: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum. RESULTS: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2). CONCLUSIONS: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference. TRIAL REGISTRATION: Trial registration: ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search.
format Online
Article
Text
id pubmed-9803154
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-98031542022-12-31 The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial Parsons, Judith Forde, Rita Brackenridge, Anna Hunt, Katharine F. Ismail, Khalida Murrells, Trevor Reid, Anna Rogers, Helen Rogers, Rebecca Forbes, Angus PLoS One Research Article OBJECTIVES: To assess the feasibility of an ante- and post-natal lifestyle intervention for women with gestational diabetes mellitus (GDM) to reduce type 2 diabetes risk. DESIGN: A partially randomised patient preference feasibility trial. SETTING: Diabetes antenatal clinics in two inner-London hospitals, UK. PARTICIPANTS: Pregnant women ≥18 years with a GDM diagnosis and pre-pregnancy body mass index of ≥25kg/m(2). INTERVENTION: Participants in the intervention group were offered four motivational interview-based sessions (two antenatally and two postnatally, at 3 and 6 months postpartum), a WhatsApp support group, a FitBit and electronic self-help resources. OUTCOME MEASURES: Recruitment; retention; intervention dose received; data completion; adaptions; proportion achieving ≥5% weight loss; weight change, blood glucose; blood pressure; diet, physical activity, breastfeeding and depression. Clinical outcomes were measured at baseline and 6 months postpartum. RESULTS: 50 participants were recruited from 155 eligible women (32% recruitment rate). Thirty-four were recruited to the intervention group (23 following randomisation (RI-group) and 11 based on preference (PI-group)); and 16 to the control group (13 randomised (RC-group) and 3 preference (PC-group)). Attrition was 44% (n = 22/50). Forty-six percent (n = 6) of the intervention group (25% (n = 2) of the RI-group and 80% (n = 4) of the PI-group) achieved ≥5% weight loss compared to 8% (n = 1) in the control group (95% confidence interval (CI) -0.69 to 0.07). Mean weight change was -2.1kg±9.0 in the intervention group (0kg±5.4 in the RI-group and -5.4kg±13.0 in the PI-group) compared to +4.4kg±4.9 in the control group (RC +4.4kg ±5.3 and PC +4.7kg ±3.1, 95% CI -12.4 to 0.2). CONCLUSIONS: Recruitment was feasible, but strategies to improve retention are needed. The findings suggest the intervention can support women with GDM to lose weight. The observed weight loss was primarily in women who preferred the intervention. Therefore, future trials may need to adopt a preference design and consider factors associated with preference. TRIAL REGISTRATION: Trial registration: ISRCTN52675820 https://www.isrctn.com/ISRCTN52675820?q=ISRCTN52675820&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search. Public Library of Science 2022-12-30 /pmc/articles/PMC9803154/ /pubmed/36584120 http://dx.doi.org/10.1371/journal.pone.0273992 Text en © 2022 Parsons et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Parsons, Judith
Forde, Rita
Brackenridge, Anna
Hunt, Katharine F.
Ismail, Khalida
Murrells, Trevor
Reid, Anna
Rogers, Helen
Rogers, Rebecca
Forbes, Angus
The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title_full The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title_fullStr The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title_full_unstemmed The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title_short The gestational diabetes future diabetes prevention study (GODDESS): A partially randomised feasibility controlled trial
title_sort gestational diabetes future diabetes prevention study (goddess): a partially randomised feasibility controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803154/
https://www.ncbi.nlm.nih.gov/pubmed/36584120
http://dx.doi.org/10.1371/journal.pone.0273992
work_keys_str_mv AT parsonsjudith thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT forderita thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT brackenridgeanna thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT huntkatharinef thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT ismailkhalida thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT murrellstrevor thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT reidanna thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT rogershelen thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT rogersrebecca thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT forbesangus thegestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT parsonsjudith gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT forderita gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT brackenridgeanna gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT huntkatharinef gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT ismailkhalida gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT murrellstrevor gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT reidanna gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT rogershelen gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT rogersrebecca gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial
AT forbesangus gestationaldiabetesfuturediabetespreventionstudygoddessapartiallyrandomisedfeasibilitycontrolledtrial